Home > Cashflow Statement > AARTI DRUGS

AARTI DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-136 Cr₹17 Cr₹92 Cr₹-81 Cr₹-215 Cr

What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?

The latest Cash Flow from Financing Activities ratio of AARTI DRUGS is ₹-136 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-136 Cr
Mar2023₹17 Cr
Mar2022₹92 Cr
Mar2021₹-81 Cr
Mar2020₹-215 Cr

How is Cash Flow from Financing Activities of AARTI DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-136 Cr
Negative
Mar2023 ₹17 Cr
-82.02
Mar2022 ₹92 Cr
Positive
Mar2021 ₹-81 Cr
Negative
Mar2020 ₹-215 Cr -

Compare Cash Flow from Financing Activities of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,499.1 Cr -7.8% -9% -25.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,044.0 Cr -0.2% -1% 9.8% Stock Analytics
DIVIS LABORATORIES ₹159,537.0 Cr -2.1% 1.5% 61.3% Stock Analytics
CIPLA ₹118,889.0 Cr -0% 2% -0.5% Stock Analytics
DR REDDYS LABORATORIES ₹102,075.0 Cr -1.4% -6.1% -4% Stock Analytics
ZYDUS LIFESCIENCES ₹94,832.5 Cr -5.2% -4.7% 8.9% Stock Analytics


AARTI DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-7.8%

-9%

-25.5%

SENSEX

-2.5%

-0.8%

7.1%


You may also like the below Video Courses